Synthesis of 4,5-dichloro-1-(4,5-dichloropyridazin-3-yl)pyridazin-6-one

DOI: 10.1002/jhet.5570360531

Source and publish data:

Journal of Heterocyclic Chemistry p. 1301 - 1306 (1999)

Update date:2022-08-04

Topics:

Authors:

Kweon, Deok-Heon

Kang, Young-Jin

Chung, Hyun-A.

Park, Jung-Won

Lee, Woo Song

Yoon, Yong-Jin

Kim, Sung-Kyu

Shiro, Motoo

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1002/jhet.5570360531

This paper presents the synthesis of 4,5-dichloro-1-(4,5- dichloropyridazin-3-yl)pyridazin-6-one from 4,5-dichloropyridazin-6-one.

Full text of DOI:10.1002/jhet.5570360531

Products guided by the article

Product name:4,4',5,5'-Tetrachloro-[1(6H),3'-bipyridazin]-6-one

Cas No:258340-49-7

R&D Labs maybe for 258340-49-7

QINGDAO HONG JIN CHEMICAL CO.,LTD.

website:http://www.hongjinchem.com

Contact:+86-532-83657313

Address:2ND Building, 8 Shangqing Road, Qingdao, Shandong Province, China.
Wuhan Chemwish Technology Co., Ltd

website:http://www.chemwish.com/

Contact:+86-27-67849912

Address:Room 1311, Unit 2, Block1, Innovation Road East Lake High-tech Development Zone Wuhan, Hubei，P.R. China
Oren Hydrocarbons (Qingdao) Co., Ltd.

Contact:+86-532-68607667-801

Address:Room 3 # 302, No.9 Qingyun Road, Qingdao, China
Improve Medical Technology(Nanxiong) Co., Ltd

Contact:86-751-3836997

Address:No.33, Pingan First Road, Fine Chemical Industry Base, Nanxiong City, Shaoguan, Guangdong, China
Xuzhou Tianrun Chemical Co.,Ltd

website:http://www.tianrunchem.cn

Contact:86-516-83832636

Address:fuxing road

Relevant to this article

Synthesis and anti-HIV activity of 1,3,4,5-tetrahydro-2H-1,4- benzodiazepin-2-one (TBO) derivatives. Truncated 4,5,6,7-tetrahydro-5- methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-ones (TIBO) analogues

Doi:10.1016/S0968-0896(99)00198-4
(1999)
Synthesis of a new chiral polyamine template - Towards an active site analogue of vanadium haloperoxidase

Doi:10.1055/s-1999-2969
(1999)
Discovery of 4,5-diphenyl-1,2,4-triazole derivatives as a novel class of selective antagonists for the human V(1A) receptor.

Doi:10.1016/S0968-0896(02)00009-3
(2002)
Asymmetric synthesis of (+)-dihydrokawain-5-ol

Doi:10.1021/jo991307n
(2000)
Use of readily available chiral compounds related to the Betti base in the enantioselective addition of diethylzinc to aryl aldehydes

Doi:10.1016/S0040-4020(99)00914-X
(1999)
Ring closure strategy leads to potent RIPK3 inhibitors

Doi:10.1016/j.ejmech.2021.113327
(2021)

Article Doi